A Genentech official tells the WSJ Health Blog that the company's morale hasn't been affected by the still-treading-water Roche buyout. Nor have employees begun to head for the doors [1]. But In the Pipeline is skeptical, both of the supposed unchanged morale and of the eventual deal itself. Report [2] | Report [3]
Links:
[1] http://www.fiercepharma.com/story/higher-genentech-bid-bigger-exodus/2008-08-21
[2] http://blogs.wsj.com/health/2008/12/03/genentech-carries-on-as-roche-deal-simmers-on-back-burner/
[3] http://pipeline.corante.com/archives/2008/12/03/roche_stalls_for_time.php